Osamu Ogawa

"Osamu Ogawa"
Mean distance: 106866
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kato M, Kobayashi T, Matsui Y, et al. (2021) Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab. International Journal of Urology : Official Journal of the Japanese Urological Association
Mizuno K, Sumiyoshi T, Okegawa T, et al. (2021) Clinical impact of detecting low-frequency variants in cell-free DNA on treatment of castration-resistant prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Taoka R, Kobayashi T, Hidaka Y, et al. (2021) Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma. Urologic Oncology
Hamada A, Sano T, Matsumoto K, et al. (2021) Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function. In Vivo (Athens, Greece). 35: 2821-2829
Aizawa R, Nakamura K, Norihisa Y, et al. (2021) Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up. International Journal of Clinical Oncology
Li X, Nakayama K, Goto T, et al. (2021) High Level of Phosphatidylcholines/Lysophosphatidylcholine Ratio in Urine is Associated with Prostate Cancer. Cancer Science
Yamashita S, Kakimoto K, Uemura M, et al. (2021) Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi-institutional, cross-sectional study. International Journal of Urology : Official Journal of the Japanese Urological Association
Kato T, Hirama H, Mitsuzuka K, et al. (2021) Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN. Prostate Cancer and Prostatic Diseases
Nishiyama N, Kobayashi T, Narita S, et al. (2021) Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching. Journal of Geriatric Oncology
Kobayashi T, Ito K, Kojima T, et al. (2021) Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR. Cancer Immunology, Immunotherapy : Cii
See more...